Our Senior Management Team
Dr. Robin Tuytten
Chief Executive Officer
Robin is a globally respected leader in the field of mass spectrometry and women’s health. Prior to his appointment as CEO Robin had been leading the Metabolomic Diagnostics R&D programs. Robin is trained as an analytical chemist and holds a PhD from the University of Antwerp where he developed methodologies for the mass spectrometric analyses of nucleosides and nucleotides. He joined Belgian biomarker company Pronota in 2006. Robin led Pronota’s Preeclampsia biomarker program until he joined Metabolomic Diagnostics. With more than 20 peer-reviewed scientific publications, co-inventorship on several technical and biomarker patent applications including protein biomarkers for PE, a solid track record in commercial biomarker development and a deep knowledge of the field of pregnancy diseases, Robin Tuytten is well positioned to lead the company’s current and future product development efforts.
Dr. Ana Panigassi
Head of Clinical Affairs and In-House Obstetrician
Ana specialises in Obstetrics and Gynaecology and Maternal-Fetal Medicine. She has several years of clinical experience as a consultant physician along with a strong academic background. She has tutored all levels of medical students and residents and is also a published author. Her most significant research was carried out with the First Trimester Screening Group at Unifesp (São Paulo, Brazil), of which she is one of the founding members. Ana moved to Ireland in 2015 and started a deep dive into Innovation in Healthcare. She began as a Fellow in BioInnovate Ireland (Ollscoil na Gaillimhe - University of Galway) in 2016 and was Clinical Mentor and a Researcher in Women's Health Innovation until 2018. She helped teams grow projects into successful early start-ups. Ana acquired another M.Sc. in Clinical Trials and Translational Research from University College Dublin and qualified as a Certified Associate in Project Management (CAPM)® and PRINCE2® Foundation Certification Training in 2021. Nowadays, Ana applies her skills at Metabolomic Diagnostics, where she works in clinical affairs, strategic planning and project management, helping the team develop solutions for risk assessment during pregnancy using precision medicine.
Dr. Greg Fitzgibbon
Clinical Laboratory Director
Greg is a Clinical Laboratory Director with New York State Department of Health Certificate of Qualification and provides the clinical expertise required for Metabolomic Diagnostics expanding business and product portfolio. Greg has previously been the COO and Clinical Affairs Director of multiple Molecular Diagnostic Companies. He has led operations teams in performing product development for In Vitro Diagnostic (IVD) products under ISO 13485 quality management systems with a focus on women's health and prenatal testing portfolios. Greg holds a Doctorate in Molecular Genetics, he is a HCPC registered Clinical Scientist and a Diplomate member of the Royal College of Pathologists. Greg has over 8 years management experience within the NHS. He has also had over 8 years involvement with the inception, growth and development of Biotechnology businesses including Syngenta, Gen-Probe, Hologic, Epistem, Elucigene Diagnostics, Yourgene Health, MyHealthChecked, on top of validating technologies for corporate giants including GSK and Government Institutions.
Dr. Paloma Muñiz Ortea
R&D Manager
Paloma is trained as an analytical chemist and holds a PhD from the Cork Institute of Technology where she developed analytical methods for the detection of marine toxins using liquid chromatography- mass spectrometry. She previously worked in Fournier Laboratories Ireland (FLI, now Abbvie) where she worked as Development analyst and Senior Analytical Scientist at a later stage. During her time at NorthStar she worked as Product Quality Manager and was responsible for ensuring the overall quality of over 30 different products currently on the market under the NorthStar label and other several affiliated labels marketed in the USA and Canada. Paloma has an extensive knowledge in method development as well as in the regulated pharmaceutical manufacturing industry.
Elizabeth Berkelaar
Office Manager/ Executive Assistant
Elizabeth's diverse experience facilitates efficient functioning of a range of office environments which she has gained over the years in various industries. Encompassing multi-operational roles, Elizabeth supports Administration, Finance, Quality, Human Resources and Health & Safety. She is a self motivated individual committed to meeting deadlines and targets with a high degree of precision and quality and adept at handling the demands of a fast-paced work environment.
Charles Garvey
Executive Chairman
Charles Garvey is a serial entrepreneur with extensive experience in growing Irish companies internationally. From 1990 to 2003 he was first COO and then CEO of Horizon Technology Group Plc. and took Horizon from a small privately held company to a major European multinational with significant global credentials. Charles took Horizon public on the London and Dublin stock exchange in 2000. Charles continued to work with Horizon right up to its sale to Avnet Corp in 2009. From 2006 to 2011 Charles was CEO of NitroSell Ltd., a SAAS based ecommerce platform, which has generated almost $1B in sales to date. Charles continues to serve as non-executive chairman of NitroSell. For the past six years, Charles has used his proven teambuilding and managerial skills to build a focused, motivated and successful team of life science professionals at Metabolomic Diagnostics. Charles has extensive experience at forging and managing partnerships with major multinational companies and in corporate finance and fundraising through angel investors, VCs, banks and public markets.
Our Advisory Team
Prof Phil Baker
Prof Louise Kenny
Declan O’Mahoney
Bill Liao
